Verified stock metrics
Halozyme Therapeutics Key Stock Metrics
Direct answer
Halozyme Therapeutics has 7 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked November 15, 2026.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $11.43B
- P/E ratio
- 25.07x
- Return on equity
- 216.38%
- Dividend yield
- 0%
- 52-week price range
- $61.23 to $134.00
- Revenue growth
- 39.2%
- Profit margin
- 26.93%
Explore related company data
View Halozyme Therapeutics's market capitalizationView Halozyme Therapeutics's p/e ratioView Halozyme Therapeutics's return on equityView Halozyme Therapeutics's dividend yieldView Halozyme Therapeutics's 52-week price rangeView Halozyme Therapeutics's revenue growthView Halozyme Therapeutics's profit marginReturn to Halozyme Therapeutics profile